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The malignant small round-cell tumors of the thoraco-pulmonary region were first described by Askin in1979.1 These tumors are characterized by neuroectoder-mal derivation and anatomic distribution. Currently,
Ewing sarcoma (ES), primitive neuroectodermal tumors (PNETs),
and malignant small round-cell tumors of the thoracopulmonary
region are suggested to be different manifestations of a single
tumor family. However, these tumors are rare and often occur in
childhood or adolescence. Only a few series have been described
in the past. We review 2 cases of patients who were referred to our
clinic, followed by a review of literature.
Clinical Summaries
PATIENT 1. A 13-year-old boy presented with a right-sided palpable
painful mass on his chest for 1 month and thoracic pain for 5
months.
There was no pain elsewhere, nor was there any dyspnea or
constitutional symptoms, such as fever and weight loss. He had no
smoking history. At physical examination, there was a slightly
prominent lateral chest wall on the right, without other signs of
pathology. A chest x-ray film showed an abnormal consolidation in
the right lateral thorax on the level of the eighth dorsal rib and
discrete pleural effusion in the right hemithorax (Figure 1).
Thoracoscopy showed a normal right upper lobe and an adhe-
sion of the middle lobe to the anterolateral chest wall with thick-
ening of the visceral pleura. The parietal pleura under this adhesion
was irregular and red colored. There was some hemorrhagic fluid
in the right thorax, showing no clear malignancy on posteroante-
rior examination. Bone scintigraphy results were positive for the
right seventh rib from the anterolateral to the dorsal position,
without other hot spots. Thoracotomy was performed for incisional
biopsy of the tumor.
Histologically, the tumor had a solid predominant lobular
growth pattern (Figure 2, A). There were fibrovascular septa be-
tween the tumor cells. There were large areas of necrosis in patient
1, whereas necrosis was absent in patient 2. The cells were round
and had scant cytoplasm with inconspicious nucleoli. Mitotic
figures were numerous. Rosettes were only focally identified.
Immunohistochemistry revealed tumor cells strongly positive for
monoclonal antibody-1, Leu-7, neuron-specific enolase (NSE),
vimentine, and CD99, a product of the MIC2 gene on the chro-
mosome (Figure 2, B). Tumor cells were negative for MNF 116,
Lu-5, neurofilament, desmine, smooth muscle actin, S100, and
CD45 (common leukocyte antigen). Focally, synaptofysine and
chromogranine were positive.
In both cases electron microscopy showed round-to-oval nu-
clei, massive glycogen, and dense core neurosecretory granules
with a diameter of 160 to 200 nm. Because of these histologic,
immunohistochemical, and electron microscopic characteristics,
the tumor was diagnosed as a PNET.
With the diagnosis of PNET, the patient underwent subsequent
thoracic surgery. There was resection of the large chest wall
soft-tissue mass of 11  7  4.8 cm, as well as the affected ribs
(Figure 3). The right fifth, sixth, and seventh ribs were resected, as
was the ventral part of the serratus anterior muscle and the inter-
costal bundle of the fourth and seventh intercostal space. The chest
wall defect was closed with Marlex mesh, as well as reconstruction
with the latissimus dorsi muscle and the dorsal part of the serratus
anterior muscle by the plastic surgeon. There was no macroscopic
direct lung invasion or lymph node involvement. Postoperatively,
there were no complications. Afterward, the patient was referred to
a pediatric oncology clinic, where he was treated with combination
chemotherapy (cyclophosphamide, doxorubicin, dactinomycin,
and vincristine). There were no signs of tumor on computed
tomographic scanning of the thorax. Fourteen months after his
initial diagnosis, he presented with bone metastasis in the lumbar
spine (L1), for which he received local radiotherapy. Shortly
thereafter, there were multiple intrapulmonary and bone metasta-
ses. Single-drug carboplatin infusions were not successful. The
patient died at home, 2 years after his initial diagnosis.
PATIENT 2. A 48-year-old woman was referred to our clinic
because of severe dorsal left-sided thoracic pain lasting several
weeks. There was no dyspnea, fatigue, or weight loss. Over 32
years, she had been smoking 1 or 2 cigarettes a day. Physical
examination was unrewarding. On the chest x-ray film, there was
an oval tumor with sharp borders in the left dorsal thorax. Fluo-
roscopy showed that the tumor was attached to the chest wall. This
was confirmed by means of computed tomographic scanning of the
thorax. Fiberoptic bronchoscopy showed a completely normal
airways system.
Bone scintigraphy showed increased uptake in the eighth dorsal
left rib, without other hot spots. Ultrasound examination of the
upper abdomen revealed no metastasis.
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A transthoracic needle biopsy was performed twice, and al-
though no certain PA diagnosis could be made, there was a high
suspicion of malignancy.
On thoracotomy, there was normal lung tissue and a large
smooth soft-tissue mass on the chest wall with a diameter of 6.5
cm, with local destruction of the ribs. Dorsal parts of ribs 7, 8, and
9 were also removed to attempt a curative resection. The postop-
erative course was uneventful.
Seven months later, the patient was admitted with pain in the
left thorax and in the right upper leg. Magnetic resonance imaging
(MRI) of the thorax and bone scintigraphy revealed local recur-
rence and multiple bone metastases in the skull, lumbar spine, and
right proximal femur. The patient was given 6 courses of etopo-
side, vincristin, actinomycin D, ifosfamide, and Adriamycin che-
motherapy. Subjectively, the patient improved because the pain in
her right leg diminished. Objectively, there was stable disease.
Because of the large tumor bulk in the thorax, new chemother-
apy did not seem a good option. Instead, a rethoracotomy was done
16 weeks after the start of chemotherapy. Tumor was seen in the
left dorsal thorax, adherent to the lung. Also, a metastasis on the
diaphragm was seen. After the debulking with resection of a
segment of the apex of the left lower lobe, the metastasis on the
diaphragm was extirpated. Four weeks after the rethoracotomy, the
patient received thoracic irradiation with a total dose of 1600 cGy
in 2 fractions in 7 days, as well as an 800-cGy irradiation on the
right femur (one dose). This was followed by 2 courses of cyclo-
phosphamide, thiotepa, and carboplatin chemotherapy. Eleven
months after the rethoracotomy, the patient received one treatment
of palliative cranial irradiation because of symptomatic brain me-
tastasis and died several weeks later, 2 years after the initial
diagnosis.
Discussion
These 2 cases illustrate 2 different presentations and the aggres-
siveness of the PNET. Both patients, one child and one adult,
presented with a chest wall localization of a PNET, also called
Askin tumor. In case 1 a 13-year-old boy presents with a tumor
from the right-sided lateral chest wall. In case 2 a 48-year-old
woman presents with a chest wall tumor and local rib destruction.
Since this tumor was first described by Askin and associates1 in
a series of 20 patients, only a few retrospective series and sporadic
case reports have been described in literature. This rare malignant
tumor is mostly found in children and is even more rare in young
adults, as in case 2.
The differential diagnosis in chest wall tumors in young pa-
tients includes ES/PNET, rhabdomyosarcoma, neuroblastoma, and
lymphoma. Diagnosis of these poorly differentiated, small round-
cell malignancies is very difficult when only based on light mi-
croscopy.
In 1979, Askin and associates1 suggested a neuroectoderm
origin on the basis of morphologic and ultrastructural findings. In
1986, Linnoila and colleagues2 were the first who confirmed a
neural phenotype by using immunohistochemistry with NSE. Al-
though the positivity for NSE could not always be found by other
investigators and the value of NSE as neural marker can be
debated, other well-recognized neural markers can confirm the
neural phenotype.3 In our study NSE results were negative in both
cases, whereas monoclonal antibody-1 results were positive.
This malignant tumor typically involves the extrapulmonary
tissue of the chest wall and the paravertebral structures as soft
tissue and periosteum. When this tumor originates in the chest
wall, as in the above-described cases, it is also called Askin tumor.
Rarely it might also involve the lung parenchyma, either as a
primary pulmonary tumor or after local spread of an adjacent
tumor. ES and PNET are histologically similar and share a specific
chromosomal abnormality, most commonly the reciprocal
t(11,22)(q24,q12) translocation. They are therefore at least closely
related and probably different manifestations of one tumor type,
with only anatomically different locations.
In our study both patients present with chest wall pain, the most
common symptom of a PNET (50%).4 The other most common
symptoms are chest wall mass (47%), dyspnea (20%), and fever
(17%). When located in the thoracopulmonary region, the tumor
site involves a chest wall mass (40%), rib involvement (37%), or
the lung parenchyma alone or with chest wall involvement (23%).
Computed tomography (CT) and MRI of the thorax mostly
show large tumors, often with a heterogeneous appearance because
of areas of hemorrhage and necrosis. CT and MRI are preferred in
detecting small pulmonary metastases and in determining invasion
of chest wall muscle, respectively. In predicting whether the ad-
jacent lung is invaded, CT and MRI are not adequate.5 PNETs
have a very high rate of local recurrence and a propensity to
metastasize. The most common sites of dissemination have been
reported in bone (35%-50%), bone marrow (29%-33%), lung
(18%-50%), liver (20%), lymph node (10%-12%) and spleen
Figure 1. Chest radiograph showing a large solid mass involving
the right thoracic wall.
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(10%), and metastases in multiple sites (35%) have also been
seen.6,7 Verrill and colleagues8 concluded that tumor burden at
presentation is the single most important prognostic factor, fol-
lowed by response to treatment, itself partly determined by tumor
size. Age was no prognostic factor in patients with ES or PNET.
The PNET is known to be highly chemoresponsive and radiore-
sponsive, as was shown with a high initial complete response of
94% in patients treated with vincristine, Adriamycin, and cyclo-
phosphamide chemotherapy plus local radiation therapy.6 How-
ever, in this study the period of observation was very short.
The best responses were reported with combinations based on
anthracyclines (doxorubicin) and high doses of alkylating agents
(cyclophosphamide or ifosfamide).7 The most frequently used
combination protocols include vincristine, actinomycin D, cyclo-
Figure 2. A, Hematoxylin-and-eosin staining of the tumor in patient 2. (Original magnification 250.) Lobular
arranged tumor cells with round-oval nuclei with numerous mitotic ıgures are shown (arrow represents mitotic
figures). B, Staining of tumor cells with CD99.
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phosphamide, doxorubicin, and ifosfamide. This is in accordance
with the chemotherapy protocols used in our above-described
patients.
Etoposide and platinum-based chemotherapy have been used in
patients with relapse, although their value has yet to be proven.
A recent phase II trial by Kushner (entitled “Phase II study of
the P6 regimen followed by radiotherapy in patients with periph-
eral neuroectodermal tumors, including Ewing’s sarcoma”) is in-
vestigating the response rate and event-free survival of patients
with PNET and ES treated with a chemotherapy regimen with
surgical intervention, followed by radiotherapy. Also, the relation
between PNET and ES will be further elucidated.
Multimodality treatment, including radical surgical resection,
neoadjuvant and adjuvant chemotherapy, and irradiation, is the
current treatment of choice. However, the preoperative diagnosis is
often very difficult to establish. Survival remains poor, with a
2-year survival of 28% to 38% and a 6-year survival of 14% to
17%.3
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Figure 3. Resection specimen showing a soft-tissue mass of 11 
7  4.8 cm with rib involvement.
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